Current developments in approaches to bridging studies

iPDM Goes Europe: tangible impact on diabetes patients and care

Dual-hormone artificial pancreas systems

Profil is co-founder of KomIT

NAFLD/NASH: a ticking bomb not yet defused

Profil joined iPDM-GO

Artificial pancreas in type 2 diabetes

Digital Diabetes: better trials, better drugs, better care

New data on cardiovascular outcomes with SGLT2 inhibitors

Profil at 18th Annual Diabetes Technology Meeting